# Sant P. Chawla, MD – FDA Inspection, Apr 15, 2022

Source: https://www.keypedia.com/records/fda_inspections/sant-p-chawla-md/fc9ea0cd-7118-4192-be16-3f8f20ae2c42
Source feed: FDA_Inspections

> FDA inspection 1167324 of Sant P. Chawla, MD, April 15, 2022. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167324
- Company Name: Sant P. Chawla, MD
- Inspection Date: 2022-04-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1324454 - 2026-06-30](https://www.keypedia.com/records/fda_inspections/sant-p-chawla-md/3c3a42fe-8e34-4a8b-8a5c-0b64111ab2b9)
- FDA Inspection 945678 - 2015-10-13
- FDA Inspection 757044 - 2011-12-13
- FDA Inspection 757043 - 2011-11-30
- FDA Inspection 722028 - 2011-04-29

Company: https://www.keypedia.com/companies/sant-p-chawla-md/12b13bee-4e0f-4d72-a3a7-217e48fb68ef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
